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http://dx.doi.org/10.1016/j.gmbhs.20Abstract The goal of this study was to investigate the effects of the hydro - methanolic (2:3)
extract of the seed of Swietenia mahagoni (L.) Jacq. for the management of streptozotocin
(STZ)-induced diabetes. Wistar rats were divided equally into four groups (n Z 6): normal
control, diabetes control, diabetes þ extract treated, and diabetes þ metformin treated.
The extract (25 mg/100 g by weight) and metformin (2.5 mg/100 g by weight) were adminis-
tered once a day, orally by gavages for 21 days at fasting condition. Hexokinase, glucose-6-
phosphate dehydrogenase, and glucose-6-phosphatase activities were measured in hepatic
tissue. Activities of catalase (CAT), peroxidase (Px), and superoxide dismutase (SOD), along
with the quantity of thiobarbituric acid reactive substances (TBARS) and conjugated diene
(CD) in hepatic and renal tissues, were assessed. Histoarchitecture of the pancreas and serum
insulin level were also evaluated. Significant diminution in the activities of hepatic hexokinase
and glucose-6-phosphate dehydrogenase along with elevation in glucose-6-phosphatase were
noted in STZ-induced animals with diabetes in respect to control animals. Level of fasting
blood glucose (FBG) was elevated in animals with diabetes. Activities of CAT, Px, and SOD were
diminished significantly along with the elevation in TBARS and CD levels in animals witht of Bio-Medical Laboratory Science and Management (UGC Innovative Funded Department),
dia.
hoo.co.in (D. Ghosh).
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108 T.K. Bera et al.diabetes. Diameter of pancreatic islets, count of islets, and degeneration in pancreatic acini
were also noted in animals with diabetes. Treatment of these animals with extract or metfor-
min resulted in substantial recovery in the aforementioned biosensors toward the control
level. This recovery is not equal to metformin because the plant extract is not the pure form
of effective ingredient(s) but provides insight to the pharmaceutical industries that the extract
has a protective therapeutic effect against diabetes through ß-cell regeneration capacity.
Copyright ª 2012, Taiwan Genomic Medicine and Biomarker Society. Published by Elsevier
Taiwan LLC. All rights reserved.Introduction
Diabetes is becoming the so-called killer disease, after
cancer and cardiovascular diseases, because of its high
prevalence, morbidity, and mortality.1 Several reports
indicate that the annual incidence of diabetes mellitus will
increase worldwide in the future, especially in India.
Currently, there are more than 150 million people in whom
diabetes mellitus has been diagnosed and another 314
million with impaired glucose tolerance, a prediabetic
state.2 It has been predicted that approximately 57 million
Indians will be affected by diabetes mellitus in 2025.2 Dia-
betes mellitus is a syndrome, associated with hyperglycemia
hyperlipidemia, oxidative stress, polyuria, polyphagia, pol-
ydypsia, ketosis, neuropathy, nephropathy, and cardiovas-
cular disorders.3,4 Diabetes is also associated with decline in
sexual function in both male and female individuals.5,6 Type
1 diabetes mellitus is a complex disease where by carbohy-
drate and fat metabolism are impaired.3 Insulin-dependent
diabetes mellitus is noted in both adulthood and child-
hood.7 In modern medicine, no satisfactory, effective
therapy is available to cure diabetes mellitus. Although
insulin therapy is also used for the management of diabetes
mellitus, there are several drawbacks such as insulin resis-
tance, anorexia nervosa, brain atrophy, and fatty liver after
chronic treatment.8,9 Oxidative stress induced by chronic
hyperglycemia has been associated with dysfunction and
apoptosis of several cell types, including pancreatic ß cells,
neurons, and glial cells.10,11 Oxidative stress results from
overproduction of reactive oxygen species coupled with
insufficient antioxidant capacity. For the treatment of dia-
betic complications, several synthetic drugs are used that
have many adverse effects such as nausea, vomiting,
cholestatic jaundice, agranulocytosis, aplastic and hemo-
lytic anemia, generalized hypersensitivity reactions,
dermatologic reactions, and lactic acidosis.12
Many traditional treatments have been recommended in
the complementary and alternative system of medicine for
the treatment of diabetes mellitus. In India, herbal drugs
are used based on Ayurveda, a common Hindu practice
which is less expensive than traditional drugs. The herbal
drugs considered of less toxic with fewer side effects
compared with synthetic drugs.13 For various reasons,
currently there has been a surge in popularity of traditional
and complementary medicine for the treatment of disease.
More than 400 species have been reported to display anti-
diabetic effects, but only a few of them have thoroughly
investigated.14 We have already screened some antidia-
betic plants and reported their efficacy in this regard.15,16The plant Swietenia mahagoni (L.) Jacq. is a beautiful,
lofty, evergreen large tree, native to tropical America,
Mexico, and South America as well as India. Usually this
plant is 30e40 m high and 3e4 m in girth. S. mahagoni is
a large medicinally and economically important timber tree
native to the West Indies. The aqueous extract of the seed
of S. mahagoni is widely used in Indonesia as folk medicine
to cure diabetes. The local people of West Bengal tradi-
tionally used the seed of S. mahagoni for curing diabetes.
There is a single report about the antidiabetic effect of
S. mahagoni in model animals. In this report blood glucose
level was monitored without further extensive investiga-
tion.17 The current study was undertaken to investigate the
antihyperglycemic and antioxidative activity of hydro-
methanol i.e. (2:3) extract of the seed of S. mahagoni in
STZ-induced diabetic male rats.
Materials and methods
Plant materials
The seeds of S. mahagoni (L.) Jacq., under the family
Meliaceae, were collected from Medinipur, District Paschim
Medinipur, West Bengal, India, in the month of December.
The materials were taxonomically identified by Prof. R. K.
Bhakat, Department of Botany and Forestry, Vidyasagar
University, Medinipur. The voucher specimen was deposited
in the Department of Botany, Vidyasagar University
(Ref. No. S. mahagoni (L.) Jacq./VU/01/09).
Preparation of hydro - methanolic (2:3) extract of
the seed of S. mahagoni (L.) Jacq.
Fresh seeds were dried in an incubator for 2 days at 40C,
crushed separately in an electric grinder, and then
pulverized. Out of this powder, 50 g was suspended in
100 mL water and 150 mL methanol (2:3) and kept in an
incubator at 37C for 36 hours. The slurry was stirred
intermittently for 2 hours and left overnight. The mixture
was then filtered and filtrate was dried by low pressure.
From that amount 9 g of light-brown residue was collected.
The residue was suspended in water in a fixed dose and
used for treatment.
Chemicals and reagents
STZ was purchased from Sigma Aldrich, New York, USA.
Other chemicals were purchased from Sigma-Aldrich
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was obtained from Aventis Pharmacy Ltd., Goa, India.
Biochemical kits were purchased from Span Diagnostic Ltd.,
Surat, India. Blood glucose levels were measured using
a one-touch electronic glucometer from Ascensia Entrust,
Bayer Diagnostics Ltd., Borada, India.
Selection of animals and animal care
The study was conducted on matured Wistar strain male
albino rats 3 months of age and weighing approximately
150 10 g. Animalswere acclimated for a period of 15 days in
our laboratory conditions prior to the experiment. Rats were
housed in Tarson cages (Tarson Products Pvt. Ltd., Kolkata,
India) at an ambient temperature of 25 2C with a 12-hour
light:12-hour dark cycle. Rats have free access to standard
food and water ad libitum. The principles of Laboratory
Animal Care (NIH, 1985) were followed throughout the
duration of the experiment and an instruction given by our
institutional ethical committee (IEC) was followed regarding
injection and other treatment of the experiment. Normo-
glycemic animals selected for this experiment had a fasting
blood glucose level of 75  5 mg/dL.
Induction of diabetes mellitus
STZ-induced diabetes was made by our standard method as
mentioned earlier.18 In brief, 24-hour fasting rats were
subjected to a single intramuscular injection of STZ at the
dose of 4 mg/0.1 mL of citrate buffer (pH 4.5)/100 g body
weight/rat that produce type 1 diabetes after 24 hours of
injection with fasting blood glucose (FBG) level higher than
250 mg dL. Diabetic state was monitored for 7 successive
days. Thirty rats were subjected for STZ injection; of these,
18 with stable diabetes and a fasting blood glucose level
higher than 250 mg/dL were selected as diabetic rats in this
experiment.
Animal treatment
Twenty-four rats were divided into the following four equal
groups for the 28-day experiment:
Group I (normal control) received a single intramuscular
injection of citrate buffer (0.1 mL/100 g body weight per
rat) and these rats were normoglycemic and had a FBG level
of 75  5 mg/dL. Group II (diabetic control) rats were made
diabetic by a single intramuscular injection of STZ at a dose
of 4 mg/0.l mL citrate buffer/100 g body weight per rat.
Group III (diabetic þ S. mahagoni) rats with diabetes of this
group were force-fed by gavage of hydro - methanolic (2:3)
extract of the seed of S. mahagoni at a dose of 25 mg/
0.5 mL water/100 g body weight per rat per day for 21 days
at fasting state. Group IV (diabetic þ metformin) rats with
diabetes received metformin at the dose of 2.5 mg/0.5 mL
water/100 g body weight per rat per day for 21 days.
Starting from the first day of extract treatment of rats
with diabetes, FBG levels in all the groups was measured by
single touch glucometer on every 7th day. On the 22nd day
of the experiment (29th day from the day of STZ injection),
all the animals were sacrificed by decapitation after
recording the final body weight. Blood was collected fromthe dorsal aorta using a syringe. Serum was separated from
a part of the collected blood by centrifugation at 3000 g for
5 minutes for the evaluation of serum glutamic pyruvic
transaminase (SGPT) and serum glutamic oxaloacetic
transaminase (SGOT) activities and insulin level. Remaining
blood was used for the quantification of glycated hemo-
globin (HbA1c). The liver, kidney, and skeletal muscle were
removed via dissection and stored at -20C. The activities
of key carbohydrate metabolic enzymes, such as hexoki-
nase, glucose-6-phosphate dehydrogenase, and glucose-6-
phosphatase, were measured biochemically. For the
assessment of oxidative injury, if present, in metabolic
organs, the activities of antioxidative enzymes such as
catalase (CAT), peroxidase (Px), and superoxide dismutase
(SOD) as well as quantification of lipid peroxidation levels,
i.e., conjugated diene (CD) and thiobarbituric acid reactive
substances (TBARS) in liver and kidney tissues, were
measured. Glycogen levels were also determined in the
liver and skeletal muscle. The middle part of pancreas were
dissected and stored in Bouin’s fixative for histological
study.
Measurement of FBG level
At the time of grouping of the animals, FBG level was
measured. On every 7th day of treatment, FBG was further
recorded from all the animals of all groups. Blood was
collected from the tip of the tail vein or by orbital puncture
alternatively and FBG levels were measured by single-touch
glucometer.
HbA1c level
HbA1c level was measured according to a standard
protocol.19 For this purpose, 4 mL of blood was collected in
an ethylene diamine tetra-acetic acid tube and plasma was
separated. The packed cells were washed six times with
normal saline. The hemolysate was prepared by adding one
fourth part distilled water and one fourth part carbon
tetrachloride to the packed cell and centrifuged at
3000 rpm for 20 minutes. Hemoglobin (Hb) concentration
was measured from the hemolysate by cyanmethemoglobin
method. Hb concentration was adjusted to 10 mg/dL using
normal saline. The 2 mL hemolysate was taken having level
of 10 mg/dL Hb and it was mixed with 1.0 mL of 0.3 N oxalic
acid. The mixture was kept in a boiling water bath for 1
hour and then cooled to room temperature; 1 mL 40% tri-
chloroacetic acid (TCA) was added. The content was mixed
and centrifuged at 3000 rpm, and supernatant at a volume
of 2 mL was collected and 0.5 mL of 0.7% thiobarbituric acid
(TBA) was added; the mixture was kept at 37

C for 40 min. A
reading was taken against blank consisting of 2 mL distilled
water and 0.5 mL TBA at 443 nm.
Biochemical assay of hexokinase
Hexokinase activity in hepatic tissue was determined
spectrophotometrically using assay mixture.20 The assay
mixture contained 3.7 mM glucose, 7.5 mM magnesium
chloride, 11 mM thioglycerol, and 45 mM HEPES [(4-(2
-hydroxyethy)-1-piperazineethanesulfonic acid)] buffer.
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buffered saline (pH 7.4) at a tissue concentration of 50 mg/
mL. In a spectrophotometer cuvette 0.9 mL of assay
mixture and 0.22 M 0.03 mL ATP (adenosine triphosphate)
was mixed well. Next, 0.1 mL of tissue supernatant was
added to the cuvette, and absorbance was noted at
340 nm. One unit of hexokinase was expressed as mg/mg of
tissue.Biochemical assay of glucose-6-phosphate
dehydrogenase
Liver glucose-6-phosphate dehydrogenase activity was
measured spectrophotometrically.21 One unit of enzyme
activity is defined as the quantity that catalyzes the
reduction of 1 mM of nicotinamide adenine dinucleotide
phosphate per minute. Activity of this enzyme was recor-
ded by using glucose-6-phosphate as a substrate and
absorbance was measured at 340 nm.Biochemical assay of glucose-6-phosphatase
activity
The hepatic glucose-6-phosphatase activity was measured
according to standard protocol.22 Tissue was homogenized
in ice-cold 0.1 M phosphate buffered saline (pH Z 7.4) at
the tissue concentration of 50 mg/mL. In a calibrated
centrifuge tube, 0.1 mL 0.1 M glucose-6-phosphate solution
and 0.3 mL of 0.5 M maleic acid buffer (pH 6.5) were taken
and brought to 37C in a water bath for 15 minutes. The
reaction was stopped with 1 mL of 10% TCA followed by
chilling in ice and centrifuged at 3000 g for 10 minutes.
The optical density was noted at 340 nm. The enzyme
activity was expressed as mg of inorganic phosphate liber-
ated per gram of tissue.Biochemical assay of glycogen content
Glycogen levels in liver and skeletal muscle were measured
biochemically.23 Tissue was homogenized in 80% ethanol
and extract was collected by centrifugation using anthrone
reagent, and quantity of glycogen was measured in relation
to standards, which was expressed in microgram of glucose
per milligram of tissue.Biochemical assay of CAT activity
The activity of catalase of the hepatic and renal tissues was
measured biochemically.24 For the evaluation of catalase
activity, the target organ of each animal was homogenized
separately in 0.05 M Tris-hydrochloric acid (HCl) buffer
solution (pH 7.0) at the tissue concentration of 50 mg/mL.
These homogenized samples were centrifuged at 10,000
rpm at 4C for 10 minutes. In a spectrophotometer cuvette,
0.5 mL 0.00035 M H2O2 and 2.5 mL distilled water were
mixed and absorbance was read at 240 nm. Supernatant of
sample was added at a volume of 40 mL and the subsequent
six readings were noted at 30-second intervals.Biochemical assay of Px activity
The Px activity was measured in target tissues according to
the standard method.25 The samples were homogenized in
ice-cold 0.1 M phosphate buffered saline (pH 7.0) at the
tissue concentration of 50 mg/mL. Next, 20 mM guaiacol
was mixed with 0.1 mL supernatant collected from the
homogenate. In the presence of 0.3 mL of 12.3 mM
hydrogen peroxide (H2O2), the time was recorded for an
increase in the absorbance by 0.1 at 436 nm.
Assay of SOD activity
Tissues were homogenized in chilled 100 mM/L Tris HCl
buffer containing 0.16 M/L potassium chloride (pH 7.4) to
give a tissue concentration of 10% (weight/volume) and
centrifuged at 10,000 rpm for 20 minutes at 4C. The SOD
activity of the sample was estimated by measuring the
percentage inhibition of the pyrogallol auto oxidation by
SOD according to the standard method.26 In a spectropho-
tometric cuvette, 2.04 mL of Tris buffer (pH 8.2), 20 mL of
sample, and 20 mL of pyrogallol were taken and the
absorbance was noted with spectrophotometry at 420 nm
for a 3-minute period. One unit of SOD was defined as the
enzyme activity that inhibits the autooxidation of pyro-
gallol by 50%.
Estimation of lipid peroxidation from concentration
of TBARS and CD
Hepatic and renal tissues were homogenized at the tissue
concentration of 50 mg/mL in 0.1 M of ice-cold phosphate
buffer (pH 7.4) and the homogenates were centrifuged at
10,000 g at 4C for 5 minutes individually. Each super-
natant was used for the estimation of TBARS and CD. For
the measurement of TBARS, the homogenate mixture of
0.5 mL was mixed with 0.5 mL of normal saline (0.9 g
sodium chloride dissolved in 100 mL distilled water) and
2 mL TBA-TCA mixture (0.392 g TBA in 75 mL 0.25 N HCl
with 15 g TCA; the volume of the mixture was made up to
100 mL by 95% ethanol) and boiled at 100C for 10 minutes.
This mixture was then cooled at room temperature and
centrifuged at 4000 g for 10 minutes. The entire super-
natant was taken in spectrophotometer cuvette and read
at 535 nm.27
Quantification of the CD was performed by a standard
method.28 The lipids were extracted with chloroform-
methanol (2:1) mixture followed by centrifugation at
1000 g for 5 minutes. The chloroform layer was evapo-
rated to dryness under a stream of nitrogen. The lipid
residue was dissolved in 1.5 mL cyclohexane and the
absorbance was noted at 233 nm to measure the amount of
hydroperoxide formed.
Biochemical assay of SGOT and SGPT
The activities of GOT and GPT in serum were measured by
specific kits supplied by Span Diagnostic Ltd., Surat, India.
The activities of these enzymes were expressed as IU/L of
serum.29
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Serum insulin was measured with an enzyme-linked immu-
nosorbent assay (ELISA) kit (Bochringer Mannheim Diag-
nostic, Mannheim, Germany).30 The intra-assay variation
was 4.9%. As the sample were run at a time, so there is no
interassay variation. The insulin level in serum was
expressed in m IU/mL.
Histopathological study of the pancreas
Pancreatic tissue was dissected from all the groups and
fixed in Bouin’s fixative. After 24 hours, small pieces of
pancreatic tissue were dehydrated in an ascending ethanol
gradient and cleared with xylene. These samples were
subjected to paraffin embedding followed by section
cutting (5 micro meter) with Leica microtome (Leica Bio-
system). Deparaffinized sections were stained with hema-
toxylin and eosin. Histological examinations were carried
out on stained sections with a computer-aided micropho-
tography system. Diameters of the pancreatic islets were
measured by Avar Cap (Avatar Capture) (Version-2.5;
AVerMedia Technologies Inc.) and Dewinter Caliper Pro 3.0
software (Dewinter Optical Inc.). Islet cells were counted
per islet under 1000 magnifications. Islet count per
specific parts of the pancreas was performed by total
scanning of the section under a microscope.16
Statistical analysis
Analysis of variance followed by multiple comparison two-
tail Student t test was used for statistical analysis of
collected data by Origin 6.1 software (Origin Lab Corpora-
tion).31 Differences were considered significant at the
levels of p < 0.001, p < 0.01, and p < 0.05. All of the values
were indicated in the tables and figures as mean  standard
error of the mean.
Results
Body weight
Body weight was significantly decreased in STZ-induced
animals with diabetes compared with the control animals.
Treatment of animals with diabetes with the extract (at theTable 1 Effect of hydro - methanolic (2:3) seed extract of Swie
glycated hemoglobin levels in streptozotocin-induced diabetic m
Groups Body weight (g)
Initial Final
Normal control 151.65  2.21 162.32 
Diabetic control 153.20  1.9 121.37 
Diabetic þ S.mahagoni 154.04  2.1 168.67 
Diabetic þ metformin 153.26  2.4 160.08 
All values are expressed as mean  standard error of the mean, n Z
Student ‘t’ test. *p < 0.001; yp < 0.05 compared with normal controdose of 25 mg/0.5 mL water per 100 g body weight per rat)
resulted in a significant recovery of body weight toward the
control level. Metformin treatment of the animals with
diabetes (at the dose of 2.5 mg/0.5 mL water per 100 g
body weight per rat) resulted in body weight resettlement
to the control level (Table 1).
Hb and HbA1c levels
There was a substantial rise in HbA1c levels along with
a decrease in Hb levels in STZ-induced diabetic animals in
comparison with the control animals. Treatment of the
animals with diabetes with the extract or metformin at the
aforementioned doses resulted in substantial recovery in
the levels of Hb and HbA1c towards the control level
(Table 1).
FBG level
Twenty-four hours after STZ injection, a substantial rise in
FBG levels was noted in STZ-induced rats with diabetes
compared with the normal control animals. Treatment of
rats with diabetes with the extract resulted in a marked
recovery of FBG levels toward the control level. Metformin
treatment of animals with diabetes resulted in resettle-
ment of this parameter to the control level (Table 2).
Carbohydrate metabolic enzyme activities in
hepatic tissue
STZ-induced rats with diabetes showed a substantial
decrease in the activities of key carbohydrate metabolic
enzymes in hepatic tissue, i.e., hexokinase and glucose-6-
phosphate dehydrogenase along with the increase in
glucose-6-phosphatase activities in comparison with the
normal control animals. Treatment of these animals with
extract or metformin at fasting state resulted in marked
recovery of the activities of these enzymes in hepatic tissue
toward the control level (Fig. 1).
Glycogen contents
Glycogen contents in hepatic tissue and skeletal muscle
were substantially decreased in STZ-induced animals with
diabetes compared with the control animals. Oral admin-
istration of extract or metformin at the aforementionedtenia mahagoni (L.) Jacq. on body weight, hemoglobin, and
ale albino rat.
Hemoglobin (g dL) Glycated
hemoglobin (GHb %)
2.3 13.82  0.78 2.18  0.06
2.2* 5.03  0.15* 5.64  0.20*
2.6y 9.28  0.37y 3.67  0.09y
2.3 12.43  0.4 3.78  0.1y
6. Analysis of variance followed by multiple comparison two-tail
l rats.
Table 2 Corrective role of hydro - methanolic (2:3) seed extract of Swietenia mahagoni (L.) Jacq. on fasting blood glucose
level in streptozotocin-induced diabetic male albino rat.
Group Fasting blood glucose level (mg/dL)
0 day 1st day 7th day 14th day 21st day 28th day
Normal control 72.34  3.7 73.21  4.8 72.86  4.9 73.51  4.7 72.02  4.6 73.68  4.7
Diabetic control 76.41  3.9 295.21  5.2* 316.32  5.8* 322.54  6.2* 315  5.9* 322.52  6.5*
Diabetic þ S. mahagoni 75.43  3.21 292.52  4.7* 244.16  3.28* 192.67  4.2* 129.5  4.1* 97.67  3.2y
Diabetic þ metformin 73.61  4.1 298.52  4.5* 225.31  4.8* 179.7  3.12* 123.61  4.5* 80.12  4.9#
All values are expressed as mean  standard error of the mean, n Z 6. Analysis of variance followed by multiple comparison two-tail
Student ‘t’ test. *p < 0.001, yp < 0.01, and #p < 0.05 compared with normal control rats.
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in glycogen in hepatic tissue and skeletal muscle toward the
control level (Fig. 2).Hepatic and renal antioxidant enzymes activities
and lipid peroxidation levels
Enzymatic antioxidant activities such as CAT, Px, and
SOD were substantially decreased in hepatic and renal
tissues of STZ-induced diabetic animals in comparison
with the control animals. Lipid peroxidation levels such
as TBARS and CD in hepatic and renal tissues were
substantially increased in STZ-induced diabetic animals in
comparison with the control animals. Oral administration
of hydro - methanolic (2:3) extract of the seed of S.
mahagoni for 21 days at the dose of 25 mg/0.5 mL water
per 100 g body weight per rat or metformin (10 mg/
0.5 mL water) to the STZ-induced diabetic animals at
fasting state resulted in substantial correction in the
activities of these enzymes and lipid peroxidation levels
in hepatic and renal tissue near to the normal values
(Tables 3 and 4).Figure 1 Effect of hydro - methanolic (2:3) extract of the seed of
phosphate dehydrogenase, and glucose-6-phosphatase activities in
expressed as mean  standard error of the mean, nZ 6. Analysis o
‘t’ test. *p < 0.001; yp < 0.05 compared with normal control rats.Activities of SGOT and SGPT
Activities of transaminase enzymes, i.e., SGOT and SGPT,
were increased significantly in diabetic animals in
comparison with the control animals. After treatment of
animals with diabetes with hydro - methanolic (2:3) extract
of the seed of S. mahagoni or metformin at the afore-
mentioned dose at fasting state, there was a substantial
decrease in the activities of SGOT and SGPT towards the
control level (Fig. 3).
Serum insulin level
Serum insulin level was decreased substantially in STZ-
induced animals with diabetes in comparison with control
animals. Substantial recovery of the level of serum insulin
towards the control level was noted after treatment with
extract or metformin for 21 days (Table 5).
Histoarchitecture of the pancreas
Diameters of pancreatic islets, count of islets, and islet
cells per islet were substantially decreased; degenerationS. mahagoni (L.) Jacq. or metformin on hexokinase, glucose-6-
hepatic tissue of STZ-induced diabetic male rat. All values are
f variance followed by multiple comparison two-tailed Student
Figure 2 Significant correction in the levels of glycogen in liver and skeletal muscle after treatment of hydro - methanolic (2:3)
extract of seed of S. mahagoni (L.) Jacq. or metformin in STZ-induced diabetic male rat. All values are expressed as
mean  standard error of the mean, n Z 6. Analysis of variance followed by multiple comparison two-tail Student ‘t’ test.
*p < 0.001; yp < 0.05 compared with normal control rats.
Glycemic disorders management by herbal extract 113of pancreatic acini was also noted in the STZ-induced
diabetic group in comparison with normal control animals.
Treatment with extract or metformin at the aforemen-
tioned doses resulted in marked recovery of these param-
eters toward the control level (Table 5 and Fig. 4).Discussion
STZ is a nitrosourea compound produced by Streptomyces
achromogenes, which specifically induces DNA strand
breakage in ß cells and causes diabetes mellitus. Therefore,
the STZ-induced diabetic model has been widely used to
induce diabetes in experimental animals as well as in our
previous work.18
The current study was conducted to determine the
antihyperglycemic as well as the antioxidative activities of
the hydro - methanolic extract (2:3) of the seed of S.
mahagoni in STZ-induced male albino rats with diabetes.
The effect was compared with the standard drug metfor-
min. For such an assessment we have studied the levels of
FBG, Hb, and HbA1c, along with glycogen content in liver
and skeletal muscle as well as histoarchitecture of the
pancreas and serum insulin level. Activities of antioxidative
defense enzymes, i.e., CAT, Px, and SOD, and lipidTable 3 Remedial effect of hydro - methanolic (2:3) seed extrac
antioxidant enzymes and lipid peroxidation levels in streptozotoc
Groups Antioxidant enzyme a
CAT (mM of H2O2
consumption/mg of tissue/min)
Px
(Un
of t
Normal control 13.28  0.59 6.6
Diabetic control 7.84  0.44* 2.8
Diabetic þ S.mahagoni 10.28  0.57y 4.6
Diabetic þ metformin 12.69  0.58 4.8
All values are expressed as mean  standard error of the mean, n Z
Student ‘t’ test. *p < 0.001; yp < 0.05 compared with normal control
SOD Z superoxide dismutase; TBARS Z thiobarbituric acid reactive speroxidation levels, i.e., TBARS and CD in hepatic and renal
tissues of different experimental groups were assessed
because diabetes carries a strong association with oxidative
injury.32 To know the antidiabetic therapeutic activity of
the hydromethanol (2:3) extract of the seed of S. mahagoni
we have adopted biochemically the key sensors of
carbohydrate metabolic enzymes such as hexokinase,
glucose-6-phosphate dehydrogenase, and glucose-6-
phosphatase.33, 34 The glucose-6-phosphatase is an impor-
tant enzyme for the production of free glucose and it is also
under the negative control of insulin, which has been sup-
ported in this study by the increase in the activities of this
enzyme in STZ-induced diabetic rat.35 After oral adminis-
tration of the extract or metformin, a significant decrease
in the activities of these enzymes along with the increase in
serum insulin were noted, findings that are similar to those
noted by others using other plants.36 Glucose-6-phosphate
dehydrogenase uses glucose through the pentose-
phosphate pathway and its activity is also under insulin.37
Hexokinase and glucose-6-phosphate dehydrogenase are
also important carbohydrate metabolic enzymes under the
positive control of plasma insulin.38 This finding was re-
flected in this study by the decrease in the activities of
these enzymes in STZ-induced diabetic rat, as STZ
destroyed b cells of the pancreas. The same type of resultst of Swietenia mahagoni (L.) Jacq. on the activities of hepatic
in-induced diabetic rat.
ctivities Lipid peroxidation levels
it/mg
issue)
SOD
(Unit/mg
of tissue)
TBARS
(nM/mg
of tissue)
CD
(nM/mg
of tissue)
8  0.13 0.30  0.03 47.10  3.25 542.15  3.9
7  0.08* 0.17  0.01* 78.37  3.87* 593.82  3.7*
9  0.07y 0.24  0.02y 56.28  2.92y 559.16  4.2y
8  0.08y 0.28  0.03 49.37  3.10 556.98  3.65y
6. Analysis of variance followed by multiple comparison two-tail
rats. CAT Z catalase; CDZ conjugated diene; PxZ peroxidase;
ubstances.
Table 4 Effect of hydro - methanolic (2:3) seed extract of Swietenia mahagoni (L.) Jacq. on the activities of renal antioxidant
enzymes and levels of lipid peroxidation in streptozotocin-induced diabetic rat.
Groups Antioxidant enzyme activities Lipid peroxidation levels
CAT
(mM of H2O2
consumption/mg
of tissue/min)
Px
(Unit/mg
of tissue)
SOD
(Unit/mg
of tissue)
TBARS
(nM/mg
of tissue)
CD
(nM/mg
of tissue)
Normal control 3.88  0.58 1.15  0.03 0.41  0.05 29.63  1.72 267.21  4.11
Diabetic control 1.89  0.4* 0.57  0.01* 0.19  0.02* 56.21  1.9* 341.5  3.9*
Diabetic þ S.mahagoni 2.94  0.48y 0.88  0.02y 0.33  0.03y 35.58  1.87y 284.81  3.72y
Diabetic þ metformin 3.62  0.6 0.91  0.02y 0.39  0.04 30.09  2.1 288.98  3.71y
All values are expressed as Mean  SEM, nZ 6. ANOVA followed by multiple comparison two-tail Student ‘t‘ test. *p < 0.001; yp < 0.05
compared with normal control rats.
CAT Z catalase; CD Z conjugated diene; Px Z peroxidase; SOD Z superoxide dismutase; TBARS Z thiobarbituric acid reactive
substances.
114 T.K. Bera et al.were also published in our previous work.15, 37 In the rats
with diabetes treated with the extract or metformin, the
activities of these enzymes were substantially increased by
increased secretion of insulin.37, 39 Regenerative function
of b cells in the pancreas by the extract has been supported
in this study by the rise in plasma insulin as well as recovery
in the volume and diameter of islets found on micropho-
tography. Regarding the mechanism of protective functions
of b cells by the extract, hypothetical views may be stated.
One hypothetical view is that the active ingredient(s)
present in the plant source may increases the production of
transforming growth factor-b1 (TGF- b1) in plasma in indi-
viduals with of type 1 diabetes, one of the best-
characterized cytokines contributing to the induction of
peripheral immune tolerance.40 TGF- b1 may also
contribute to the formation of a so-called TGF-b1 ring
around pancreatic islets that protect the b cells against
infiltrating lymphocytes, providing a safe environment for
promotion of b cell regeneration and increased serum
insulin.41,42 Another views is that S. mahagoni brings aboutFigure 3 Resettlement in the activities of serum glutamate oxa
transaminase (SGPT) after treatment of hydro - methanolic (2:3)
diabetic male albino rat. All values are expressed as mean  stan
by multiple comparison two-tail Student ‘t’ test. *p < 0.001; yp <its hypoglycemic action by its inhibitory effect against
insulinase enzyme, increase in insulin sensitivity, or the
insulin-like activity. Peripheral utilization of glucose,
increase in synthesis of hepatic glycogen or decrease in
glycogenolysis, inhibition in intestinal glucose absorption,
or reduction of glycemic index of carbohydrates may
occur.43
Antidiabetic therapeutic effects of the extract may be
explained by the management of oxidative stress condition
in the STZ-induced rat with diabetes. The destruction of
superoxide radicals or H2O2 by SOD, CAT, or Px would
ameliorate STZ toxicity, as substances able to scavenge
hydroxyl radical. The altered balance of antioxidant
enzymes caused by decreased SOD, CAT, and Px activities
may be responsible for the inadequacy of antioxidant
defense in combating reactive oxygen species (ROS)-medi-
ated damage. Decreases in the activities of SOD, CAT, and
Px may respond to increased production of H2O2 and oxygen
by the autoxidation of glucose and nonenzymatic glyca-
tion.44 Reduced activity of SOD, CAT, and Px in hepatic andloacetate transaminase (SGOT) and serum glutamate pyruvate
extract of seed of S. mahagony or metformin in STZ-induced
dard error of the mean, n Z 6. Analysis of variance followed
0.05 compared with normal control group.
Table 5 Corrective role of hydro - methanolic (2:3) seed extract of Swietenia mahagony (L.) Jacq. on islet number, islet cell
number, diameter of islets, and serum insulin level in streptozotocin-induced diabetic male albino rat.
Groups Islet number (count
per field in 1000
magnification)
No. islet cells
/Islet
Islet diameter
(m m)
Serum insulin
(m IU/mL)
Normal control 21.04  1.53 176.3  9.01 287.85  12.04 15.28  1.03
Diabetic control 7.91  0.95* 73.1  6.1* 127.46  9.03* 3.97  0.62*
Diabetic þ S. mahagoni 17.53  1.41y 164.1  7.4y 268.92  10.47y 13.26  0.84y
Diabetic þ metformin 18.97  1.65y 166.15  8.5y 270.15  11.05y 13.84  0.98y
All values are expressed as mean  standard error of the mean, n Z 6. Analysis of variance followed by multiple comparison two-tail
Student ‘t’ test. *p < 0.001; yp < 0.05 compared with normal control rats.
Glycemic disorders management by herbal extract 115renal tissues has been observed during diabetes and this
may result in a number of deleterious effects due to the
accumulation of superoxide radicals and H2O2.
45 The
correction of lipid peroxidation in diabetes by the extract
has been confirmed by the assessment of TBARS and CD in
hepatic and renal tissues. In diabetes, hypoinsulinemia
increases the activity of the enzyme fatty acyl coenzyme A
oxidase, which initiates ß-oxidation of fatty acids, resulting
in lipid peroxidation.44 After oral administration of the
hydro - methanolic (2:3) extract of the seed of S. mahagoni
or metformin in animals with diabetes, blood glucose levels
are decreased and the formation of ROS may be hindered,
thereby protecting b cells from additional damage andFigure 4 Histology of the pancreas. (A) Normal histoarchitecture
diameter of the islet and islet cell population and degeneration pan
recovery of islet cell population and islet diameter in the extract-
recovered significantly in metformin-treated diabetic group. Hemafacilitating their regeneration and increased serum
insulin.46
Quantification of glycogen further confirms the efficacy
of the hydro - methanolic (2:3) extract of the seed of S.
mahagoni for the treatment of diabetes, which supports
the insulinotropic effect of said extract because insulin is
the main regulator of glycogen content in liver and skeletal
muscle.47 This extract has no general toxic effect as body
weights remain normal in the extract-treated diabetic
group. Moreover, there was no change in the activities of
SGOT and SGPT in the extract treated group, which high-
lights the nontoxic effect of hydro-methanol (2:3) extract
of the seed of S. mahagoni in this regard.of pancreatic islet, in the control group. (B) Diminution in the
creatic acini cells in the diabetic control group. (C) Prominent
treated diabetic group. (D) Diameter and number of islet cell
toxylin-eosin stain, original magnification 400.
116 T.K. Bera et al.Conclusion
The possible mode of action of the hydro - methanolic
extract for the diabetic therapeutic effect is the regener-
ation of acini and islets cells of the pancreas that are
damaged by STZ. As diameter and counts of islets have
been resettled toward the control level, it may be stated
that the active ingredient(s) present in this extract can
sensitize the ß cells and/or regenerate the ß cells that
elevate serum insulin level and thereby rectify glycated Hb
level (important oxidative stressor) and regulate carbohy-
drate metabolic enzymes activities and FBG level. More
work is under way in our laboratory to search for the active
ingredient(s) present in this extract responsible for this
purpose.
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